- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
 |
13th Annual
Phase I & IIa Clinical Trials
21 - 22 February 2012
|
Speaker Faculty
Expert industry speakers
- Alaa Ahmad, Director, Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb, USA
- Alan Palmer FSB, PhD, MSc, BSc, Chief Scientific Officer, MS Therapeutics Ltd., UK
- Alan Xiao, Director Clinical Pharmacology, AstraZeneca, USA
- Allison Morgan, VP Clinical Development, Prosensa, Netherlands
- Andrew Preece, Clinical Programme Lead, GSK, UK
- Anshu Vashishtha, Safety Science Leader, Genentech Inc, USA
- Armen Asatryan, MD, MPH, Medical Director, Clinical Pharmacology & Pharmacometrics, Global Pharmaceutical Research & Development, Abbott Laboratories, USA
- Barbara Warner, MD, MSRB/SIGDET Deputy Chair, Early Clinical Safety Leader, Drug Safety & Epidemiology, Novartis, USA
- Beatrice De Vos, Chief Medical Officer, Promethera Biosciences, Belgium
- Borje Darpo MD, PhD, Associate Professor of Cardiology, Global Medical Director, iCardiac Technologies Inc., Sweden
- Caroline Ward, Programme Manager, Phytopharm, UK
- Christer Gottfridsson, Cardiologist, Cardiac Safety Expert, Patient Safety, AstraZeneca R&D, Sweden
- Clare Nott, Senior Clinical Project Manager, UK
- Clemens Günther, Director, Head of Global Preclinical Development, Intendis GmbH, Germany
- Daren Austin, Head, Biopharm Clinical Pharmacology & Biometrics, GlaxoSmithKline, UK
- David Jones, Expert Pharmaco-Toxicologist, MHRA, UK
- Diep Tran, Principle Medical Advisor, LEO Pharma, UK
- E Martin O’Kane, Pharmaceutical Assessor, Clinical Trials Unit, MHRA, UK
- Fredric Steinberg, Medical Assessor, Clinical Trials Unit, MHRA, UK
- Hans Cruz PhD, Clinical Pharmacologist, Actelion Pharmaceuticals Ltd., Switzerland
- James Dow, Director of Clinical Pharmacology & DMPK, Prosidion, UK
- James Milligan MB ChB, MRCP, MFPM, Global Section Director, Safety Science, AstraZeneca, UK
- Joachim Hoechel, Global Drug Discovery - Clinical Pharmacokinetics, Bayer Pharma AG, Germany
- Johan Luthman, Early Development Leader Neuroscience & Ophthalmology R&D, Merck Research Laboratories, Merck & Co., Inc, USA
- John Lambert, MBBS, PhD, MMed, Chief Medical Officer, Early Phase, PAREXEL International
- Kenneth Carlson, Manager, Clinical Pharmacology Study Delivery Solutions (Sourcing), Eli Lilly, USA
- Krystyna Bell, Clinical Trial Manager, Clinical R&D Department, Chugai Pharma Europe Ltd, UK
- Larry Blankstein PhD, Senior Director Clinical Development, Genzyme, USA
- Laura Brown, Course Director, MSc Clinical Research, School of Pharmacy, Cardiff University and Project Management and Training Consultant in the Pharmaceutical Industry
- Maarten Timmers, Associate Director, Clinical Research Manager, Experimental Medicine, Janssen – Pharmaceutical Companies of Johnson & Johnson, Belgium
- Mark Egerton, Managing Director, Quotient Bioresearch
- Mary Reilly MSC, VP Pharmaceutical and Clinical Development, Opsona Therapeutics, Ireland
- Mendel Jansen, Director, Modelling & Simulation, Translational Medicine & Clinical Pharmacology, Daiichi Sankyo Development Ltd, UK
- Michael Merz, Director Preclinical Safety, Translational Sciences, Coordinator IMI SAFE-T consortium, Novartis, Switzerland
- Mohamed Oubihi, Regulatory Development/EU Regulatory Intelligence Lead, Biogen Idec Ltd, UK
- Nanna Keeling, MSc Dip Pharm, MRPharmS, Management Consultant, Wenell Management AB, Sweden
- Ray Harris, Senior Director, Biostatistics, Eisai, UK
- Rob Aspbury, Vice President, Clinical Pharmacology Services, Covance, UK
- Rob Middel, Head of Operations at Quality Management Center of Excellence, Global Development Organization, J&J Pharma, Netherlands
- Robert Lins, Medical Advisor of SGS Life Science Services Clinical Research and Clinical Professor at the Department of Internal Medicine, University of Antwerp
- Sabine Kaubitzsch, Medical Director, Clinical Development Department, Micromet GmbH, Germany
- Sally Hughes, Senior Director, Clinical Pharmacology & Clinical Diagnostic Services, Eli Lilly, UK
- Vanessa Lunardelli, Country Study Manager, Roche Products Ltd, Brazil
- Vikash Sinha, Associate Director, Clinical Pharmacology Leader, Johnson & Johnson, Belgium
- Walter Janssens, Coordinator Early Phase Development, FAMHP, Belgium
- Zahid Ali, Director (clinician), Pfizer, UK
Event write up 2012
Missed the event?
"Graham Hughes reviews the 13th Annual Phase 1 and 2a Clinical Trials conference,
highlighting key presentations on proof of concept and venture capital initiatives . . ."
Read the full article by clicking here
Keynote Speakers
Senior level industry decision makers including perspectives from large pharma, biotech, venture capital and financial analysts.
Click here for a full list of expert speakers
Keynote Speakers
Greg Simon
Senior Vice President, Patient Engagement Group
Pfizer
|
Paul de Koning
Vice President, Head Global Clinical Pharmacology & Exploratory Development
Astellas Pharma Global Development
|
Steve Street
Vice President for Research, Head of Pfizer R&D Continuous Improvement
Pfizer
|
James Noble
CEO
Immunocore
|
Joseph DeGeorge
Vice President, Safety Assessment
Merck Research Laboratories
|
Tony Johnson
Vice President, Discovery Medicine Clinical Pharmacology
Bristol-Myers Squibb Research
|
Kate Bingham
Managing Partner
SV Life Sciences
|
Douglas Tsao, MPH
U.S. Specialty Pharmaceuticals & CROs
Barclays Capital Equity Research
|
Stephen Unger, CFA
Director / Senior Analyst, Equity Research - Life Science Tools & Diagnostics
Lazard Capital Markets
|
Neil V. Smith
Director Regulatory Affairs
Chorus, Lilly Research Laboratories, Eli Lilly and Company, USA
|
Feeds | Like | Share    |
Latest Agenda
Download the latest agenda
Updated 14 Feb 2012
..
FREE Wine Tasting Evening
..
..
..
Join the discussions
Follow us
Buy one 2 day conference pass and get one free*
Brand new offer for 2012!
We want to make sure that you are able to attend this important industry event
*offer applicable to employees of pharmaceutical and biotech companies only
Brand new for 2012: Site Visit!
Visit the Clinical Trials Centre at St. Mary's Hospital, Imperial College Healthcare NHS Trust
Free to attend - limited space available so make sure you register and quote CQ4156D
Latest tweets
Dates and Venues
21 Feb 2012 - 22 Feb 2012
The Lancaster London
Event Sponsors
Exhibitors
